TY - JOUR
T1 - FGF-23 from erythroblasts promotes hematopoietic progenitor mobilization
AU - Ishii, Shinichi
AU - Suzuki, Tomohide
AU - Wakahashi, Kanako
AU - Asada, Noboru
AU - Kawano, Yuko
AU - Kawano, Hiroki
AU - Sada, Akiko
AU - Minagawa, Kentaro
AU - Nakamura, Yukio
AU - Mizuno, Seiya
AU - Takahashi, Satoru
AU - Matsui, Toshimitsu
AU - Katayama, Yoshio
N1 - Publisher Copyright:
© 2021 American Society of Hematology
PY - 2021/3/18
Y1 - 2021/3/18
N2 - Fibroblast growth factor 23 (FGF-23) hormone is produced by bone-embedded osteocytes and regulates phosphate homeostasis in kidneys. We found that administration of granulocyte colony-stimulating factor (G-CSF) to mice induced a rapid, substantial increase in FGF-23 messenger RNA in bone marrow (BM) cells. This increase originated mainly from CD45−Ter119+CD71+ erythroblasts. FGF-23 protein in BM extracellular fluid was markedly increased during G-CSF–induced hematopoietic progenitor cell (HPC) mobilization, but remained stable in the blood, with no change in the phosphate level. Consistent with the BM hypoxia induced by G-CSF, low oxygen concentration induced FGF-23 release from human erythroblast HUDEP-2 cells in vitro. The efficient mobilization induced by G-CSF decreased drastically in both FGF-23−/− and chimeric mice with FGF-23 deficiency, only in hematopoietic cells, but increased in osteocyte-specific FGF-23−/− mice. This finding suggests that erythroblast-derived, but not bone-derived, FGF-23 is needed to release HPCs from BM into the circulation. Mechanistically, FGF-23 did not influence CXCL-12 binding to CXCR-4 on progenitors but interfered with their transwell migration toward CXCL-12, which was canceled by FGF receptor inhibitors. These results suggest that BM erythroblasts facilitate G-CSF–induced HPC mobilization via FGF-23 production as an intrinsic suppressor of chemoattraction.
AB - Fibroblast growth factor 23 (FGF-23) hormone is produced by bone-embedded osteocytes and regulates phosphate homeostasis in kidneys. We found that administration of granulocyte colony-stimulating factor (G-CSF) to mice induced a rapid, substantial increase in FGF-23 messenger RNA in bone marrow (BM) cells. This increase originated mainly from CD45−Ter119+CD71+ erythroblasts. FGF-23 protein in BM extracellular fluid was markedly increased during G-CSF–induced hematopoietic progenitor cell (HPC) mobilization, but remained stable in the blood, with no change in the phosphate level. Consistent with the BM hypoxia induced by G-CSF, low oxygen concentration induced FGF-23 release from human erythroblast HUDEP-2 cells in vitro. The efficient mobilization induced by G-CSF decreased drastically in both FGF-23−/− and chimeric mice with FGF-23 deficiency, only in hematopoietic cells, but increased in osteocyte-specific FGF-23−/− mice. This finding suggests that erythroblast-derived, but not bone-derived, FGF-23 is needed to release HPCs from BM into the circulation. Mechanistically, FGF-23 did not influence CXCL-12 binding to CXCR-4 on progenitors but interfered with their transwell migration toward CXCL-12, which was canceled by FGF receptor inhibitors. These results suggest that BM erythroblasts facilitate G-CSF–induced HPC mobilization via FGF-23 production as an intrinsic suppressor of chemoattraction.
UR - http://www.scopus.com/inward/record.url?scp=85102651358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102651358&partnerID=8YFLogxK
U2 - 10.1182/blood.2020007172
DO - 10.1182/blood.2020007172
M3 - Article
C2 - 33512467
AN - SCOPUS:85102651358
SN - 0006-4971
VL - 137
SP - 1457
EP - 1467
JO - Blood
JF - Blood
IS - 11
ER -